期刊文献+

药源性肾上腺功能障碍 被引量:2

Drug-induced adrenal dysfunction
下载PDF
导出
摘要 药源性肾上腺功能障碍是指应用某些药物而引起的肾上腺疾病,包括皮质醇增多症、急性/慢性肾上腺皮质功能不全等。引起药源性肾上腺疾病的药物种类繁多,不同药物所致肾上腺功能异常的发生机制不同,临床表现不一。本文主要就引起肾上腺功能障碍的常见药物种类、发病机制、临床表现及诊治方法进行综述,以指导临床用药。
作者 崔佳 窦京涛
出处 《药品评价》 CAS 2014年第11期31-36,共6页 Drug Evaluation
  • 相关文献

参考文献30

  • 1朱晓洁,刘检,张予阳.2010年英文期刊罕见药源性疾病的分析[J].药物流行病学杂志,2011,20(11):599-602. 被引量:2
  • 2Itoh M.Drug-induced metabolic and endocrine disorders[J] .NihonRinsho, 2012,70 Suppl:117-126.
  • 3Leary J,Swislocki A.Hypothalamic-Pituitary-Adrenal Suppression andIatrogenic Cushing's Syndrome as a Complication of Epidural SteroidInjections[J].Case Rep Endocrinol,2013,2013:617042.
  • 4Dow A,Yu R.Carmichael J.Too little or too much corticosteroid?Coexisting adrenal insufficiency and Cushing's syndrome fromchronic,intermittent use of intranasal betamethasone [J].EndocrinolDiabetes Metab Case Rep,2013,2013:130036.
  • 5Pivonello R,De Martino MC,De Leo M,et al.Cushing5 s syndrome.Endocrinol Metab Clin North Am,2008,37(1): 135-149.
  • 6Peppa M,Krania M,Raptis SA.Hypertension and other morbidities withCushing's syndrome associated with corticosteroids:a review[J] .IntegrBlood Press Control,2011,4(3):7-16.
  • 7Iwari A,Goel M,Pal P,et al.Topical-steroid-induced iatrogenic Cushingsyndrome in the pediatric age group:A rare case report[J].Indian JEndocrinol Metab,2013,17 Suppl l:S257-258.
  • 8Namburu RP,Karthik TS,Reddy PA.Iatrogenic Cushing's Syndrome in anInfant[J]J Clin Diagn Res,2013,7(2):353-354.
  • 9McConkey HZ,Williams H,Kulasegaram R,et al.Orbital floortriamcinolone causing Cushing ’ s syndrome in a patient treated withKaletra for HIV1[J], BMJ Case Rep,2013.pii:bcr0220125849.
  • 10郭树彬.肾上腺危象的诊治[J].中国临床医生杂志,2011,39(2):6-8. 被引量:11

二级参考文献81

  • 1崔娜,刘大为.糖皮质激素在严重感染和感染性休克中的应用[J].中国危重病急救医学,2005,17(4):241-243. 被引量:30
  • 2闫利英,李随勤,施秉银,张少强,白艳霞,权芳,王林古,何文璇.甲状腺功能亢进症的外科治疗[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):595-598. 被引量:31
  • 3Arafah BM. Hypothalamic pituitary adrenal function during critical illness : limitations of current assessment methods [ J ]. J Clin Endocrinol Metab ,2006,10 ( 91 ) : 3725 - 3745.
  • 4Weitzman S,Berger S. Clinical trial design in studies of eortieosteroids for bacterial infections [ J ]. Ann lntem Med, 1974,81 ( 1 ) : 36 -42.
  • 5Schumer W. Steroids in the treatment of clinical septic shock[ J]. Ann Surg, 1976,184 (3) : 333 - 341.
  • 6Sprung CL, Caralis PV, Mareial EH, et al. The effects of high-dose corticosteroids in patients with septic shock: a prospective, controlled study[J]. N Engl J Mcd,1984,311 (18) :1137 - 1143.
  • 7Luce JM, Montgomery AB, Marks JD, et al. Ineffectiveness of highdose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock[ J]. Am Rev Respit Dis,1988,138(1) :62 -68.
  • 8Bone RC, Fisher C J, Clemmer TP, et al. A controlled clinical trial of high-dose methylprednisnlone in the treatment of severe sepsis and septic shock [ J]. N Engl J Med, 1987,317 ( 11 ) :653 - 658.
  • 9The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis[ J]. N Engl J Med, 1987,317( 11 ) :659 -665.
  • 10Cronin L, Cook D J, Carlet J, et al. Corticostereid treatment of sepsis : a critical appraisal and metaanalysls of the literature [ J ]. Crit Care Med, 1995,23 ( 8 ) : 1430 - 1439.

共引文献42

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部